{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:06:09Z","timestamp":1790895969875,"version":"4.1.0"},"reference-count":26,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The extent of clopidogrel-mediated platelet inhibition varies considerably from one person to the next. Numerous studies have shown that low responders have significantly more adverse events after coronary stenting than patients who respond well to antithrombotic treatment with clopidogrel. Dihydropyridine calcium-channel blockers (CCBs) inhibit the cytochrome P450 3A4 enzyme, which metabolises clopidogrel to its active form.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate the influence of CCBs on clopidogrel-mediated platelet inhibition.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Adenosine-5-diphosphate (ADP)-inducible platelet reactivity was assessed by light transmission aggregometry (LTA) and the VerifyNow P2Y12 assay in 162 patients after percutaneous intervention with stent implantation. Results in the fourth quartiles of both assays were considered as high on-treatment residual ADP-inducible platelet reactivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with concomitant CCB therapy showed a significantly higher on-treatment platelet reactivity than patients without CCB medication (p=0.001 for both assays). Further, high on-treatment residual ADP-inducible platelet reactivity was significantly more common among patients currently taking CCBs (p=0.001 for LTA and p=0.004 for the VerifyNow P2Y12 assay). A multivariate regression analysis confirmed CCB therapy as an independent predictor of reduced clopidogrel-mediated platelet inhibition (p=0.006 for LTA and p=0.004 for the VerifyNow P2Y12 assay).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CCBs decrease clopidogrel-mediated platelet inhibition in patients undergoing angioplasty and stenting for cardiovascular disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/hrt.2009.171488","type":"journal-article","created":{"date-parts":[[2009,8,17]],"date-time":"2009-08-17T20:18:24Z","timestamp":1250540304000},"page":"186-189","source":"Crossref","is-referenced-by-count":102,"title":["Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition"],"prefix":"10.1136","volume":"96","author":[{"given":"Thomas","family":"Gremmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Seidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Koppensteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph W","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2009,8,16]]},"reference":[{"key":"2025092001451890000_96.3.186.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi851"},{"key":"2025092001451890000_96.3.186.2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614133","article-title":"Identification and biological activity of the active metabolite of clopidogrel","volume":"84","author":"Savi","year":"2000","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.4","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.152736"},{"key":"2025092001451890000_96.3.186.5","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2008.152660"},{"key":"2025092001451890000_96.3.186.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.09.067"},{"key":"2025092001451890000_96.3.186.7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1160\/TH04-01-0049","article-title":"Variable extent of clopidogrel responsiveness in patients after coronary stenting","volume":"92","author":"Grossmann","year":"2004","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl275"},{"key":"2025092001451890000_96.3.186.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.07.041"},{"key":"2025092001451890000_96.3.186.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.06.065"},{"key":"2025092001451890000_96.3.186.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000130846.46168.03"},{"key":"2025092001451890000_96.3.186.12","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050706"},{"key":"2025092001451890000_96.3.186.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.055"},{"key":"2025092001451890000_96.3.186.14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1160\/TH08-09-0577","article-title":"Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation","volume":"101","author":"Gremmel","year":"2009","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.15","doi-asserted-by":"publisher","DOI":"10.1080\/09537100410001711505"},{"issue":"Suppl 2","key":"2025092001451890000_96.3.186.16","first-page":"15","article-title":"Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects","volume":"25","author":"Savcic","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"2025092001451890000_96.3.186.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.24.2823"},{"key":"2025092001451890000_96.3.186.18","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.10.2316"},{"key":"2025092001451890000_96.3.186.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02656.x"},{"key":"2025092001451890000_96.3.186.20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn046"},{"key":"2025092001451890000_96.3.186.21","doi-asserted-by":"publisher","DOI":"10.1080\/09537100802272634"},{"key":"2025092001451890000_96.3.186.22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1160\/TH07-07-0478","article-title":"Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment","volume":"99","author":"Sibbing","year":"2008","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1160\/TH06-05-0242","article-title":"Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood","volume":"96","author":"Toth","year":"2006","journal-title":"Thromb Haemost"},{"key":"2025092001451890000_96.3.186.24","doi-asserted-by":"publisher","DOI":"10.1021\/jm00110a012"},{"key":"2025092001451890000_96.3.186.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.064"},{"key":"2025092001451890000_96.3.186.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.09.017"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.2009.171488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:45:32Z","timestamp":1758357932000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.2009.171488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,16]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,2,4]]},"published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1136\/hrt.2009.171488"],"URL":"https:\/\/doi.org\/10.1136\/hrt.2009.171488","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,16]]}}}